# To Evaluate the Effect of Glibenclamide in Reducing Brain Edema of TBI

> **NCT05148403** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Beijing Tiantan Hospital** · enrollment: 76 (estimated)

## Conditions studied

- Traumatic Brain Injury

## Interventions

- **DRUG:** glibenclamide

## Key facts

- **NCT ID:** NCT05148403
- **Lead sponsor:** Beijing Tiantan Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-10-22
- **Primary completion:** 2022-10-01
- **Final completion:** 2022-10-01
- **Target enrollment:** 76 (ESTIMATED)
- **Last updated:** 2021-12-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05148403

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05148403, "To Evaluate the Effect of Glibenclamide in Reducing Brain Edema of TBI". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05148403. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*